Monoclonal Antibodies

Links shared publicly online about this topic

Multiple Sclerosis - Monoclonal Antibodies: What Are They?

healthcentral.com — “The Immune System: Invaders and Defenders   We are surrounded by billions of bacteria and viruses which try to invade our bodies and reproduce. We call t...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on January 20, 2010 at 4:27 pm By:

LisaEmrich Lisa Emrich Patient Expert

Monoclonal Antibodies: What are they?: The Immune System: Invaders and Defenders   We are surrounded by billions o... http://bit.ly/6GqJP5

2 years ago...

Brass and Ivory: Monoclonal Antibodies in Development for MS

brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\View full resource at brassandivory.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 2, 2010 at 5:42 pm By:

LisaEmrich Lisa Emrich Patient Expert

Monoclonal Antibodies in Development for MS: What are some monoclonal antibody treatments in development for MS? ... http://bit.ly/cgw4GH

2 years ago...

Brass and Ivory: Rituxan, Tysabri, Zenapax are Monoclonal Antibodies

brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\View full resource at brassandivory.blogspot.com

  • View Related
  • Share

Most Recently Shared on January 20, 2010 at 7:53 pm By:

LisaEmrich Lisa Emrich Patient Expert

Rituxan, Tysabri, Zenapax are Monoclonal Antibodies: Monoclonal antibodies (MABs) are a type of biological therapy... http://bit.ly/6QAk3h

2 years ago...

A Monoclonal Antibody for Multiple Myeloma - Patient Power

patientpower.info — “Dr. Robert Orlowski, from MD Anderson, explains the basics of elotuzumab.View full resource at patientpower.info

  • View Related
  • Share

Most Recently Shared on February 20, 2012 at 6:55 pm By:

patientpower Andrew Schorr Support

A Monoclonal Antibody for Multiple Myeloma - Patient Power - http://t.co/IIAVdoEg

3 months ago...

Promising Phase 1 Results For New Monoclonal Antibody to PCSK9 - Forbes

forbes.com — “Promising results from very early studies with an experimental new cholesterol-lowering drug, a monoclonal antibody to PCSK9, have been published in the New England Journal of Medicine. Evan Stein and colleagues report the results of two single-dose studies in which the drug, REGN727, was administered intravenously and subcutaneously to healthy subjects. In a [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 10:15 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Promising Phase 1 Results For New Monoclonal Antibody to PCSK9: Promising results from very early studies ... http://t.co/WSuhWPVD #drug

2 months ago...

Promising Phase 1 Results For New Monoclonal Antibody to PCSK9 - Forbes

forbes.com — “Promising results from very early studies with an experimental new cholesterol-lowering drug, a monoclonal antibody to PCSK9, have been published in the New England Journal of Medicine. Evan Stein and colleagues report the results of two single-dose studies in which the drug, REGN727, was administered intravenously and subcutaneously to healthy subjects. In a [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 1:51 am By:

Cholesterol_OW Cholesterol OW OW Health

Promising Phase 1 Results For New Monoclonal Antibody to PCSK9: Promising results from very early studies with a... http://t.co/9bbzTaec

2 months ago...

Potential Treatment For Tumors Resistant To VEGF Therapy Offered By Novel Monoclonal Antibody

medicalnewstoday.com — “Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 15, 2011 at 9:05 am By:

mnt_liver MNT Liver Disease Health News

Potential Treatment For Tumors Resistant To VEGF Therapy Offered By Novel Monoclonal Antibody http://t.co/IVv8LjnF #liver #hepatitis

6 months ago...

FDA Approves A New, Monoclonal Antibody For Lymphoma - Better Health

getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.View full resource at getbetterhealth.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 9:24 pm By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

FDA Approves A New, Monoclonal Antibody For Lymphoma: Recently, the FDA announced its approval, upon acce... http://t.co/EB5I1vj #news

9 months ago...

REGN727 Monoclonal Antibody Lowers LDL Cholesterol --Doctors Lounge

doctorslounge.com — “REGN727 Monoclonal Antibody Lowers LDL Cholesterol --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 12:16 am By:

Endocrinology News - Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol |3991613

mdlinx.com — “Endocrinology Medical Article: Effect of a Monoclonal Antibody to PCSK9 on LDL CholesterolView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:15 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol: New England Journal of Medicine http://t.co/ZCz79c4j #endo

2 months ago...

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

news-medical.net — “AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 3:19 pm By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting: AVEO Ph... http://bit.ly/g0pgcu

1 year ago...

Research and Markets: Cancer Monoclonal Antibodies Market to 2015 - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: DUBLIN-- -- Dublin - Research and Markets has announced the addition of the "Cancer Monoclonal Antibodies Market to 2015" report to their offering. Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease ...View full resource at finance.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:07 pm By:

Cancer_Wisdom Cancer OW OW Health

Research and Markets: Cancer Monoclonal Antibodies Market to 2015: DUBLIN-- -- Dublin - Research and Markets has... http://t.co/P5jBPFcz

2 months ago...

Monoclonal Antibodies-Reports from Dartmouth University advance knowledge in...

newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.View full resource at newsrx.com

  • View Related
  • Share

Most Recently Shared on August 15, 2009 at 1:01 pm By:

NewsRx NewsRx Medical News Health News

Reports from Dartmouth University advance knowledge in monoclonal antibodies...http://bit.ly/CtpVb

3 years ago...

Yervoy: a novel monoclonal antibody for the treatment of skin cancer. | MIMS online

mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS onlineView full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 8:30 am By:

mimsonline MIMS Online Medical Publisher

New to MIMS for September: Yervoy, a monoclonal antibody for advanced melanoma: http://t.co/44nUVv5

9 months ago...

Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy

aacr.org — “Shutting down the ALK-1 receptor inhibits the VEGF pathway. Response seen in patients who had used antiangiogenic therapy. VEGF therapies might work best in combination. SAN FRANCISCO — Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancer cells. Now, a study reported at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer TheView full resource at aacr.org

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 5:57 am By:

libbyshope Paul Cacciatore Patient Advocate

Novel Monoclonal Antibody PF-03446962 Offers Potential Treatment 4 Tumors Resistant 2 VEGF Therapy 2011 AACR-NCI-EORTC http://t.co/mI89ZZq6

6 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

  • LisaEmrich

    Lisa Emrich

    Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390